Particle.news
Health ❯ Healthcare ❯ Pharmaceuticals
FDA FDA Actions Mifepristone FDA Decisions Counterfeit Drugs GLP-1 Drugs FDA Oversight Compounding Pharmacies Anvisa Actions Quality Control
The committee found the pivotal ADVOCATE trial breached good clinical practice and persistent reports of serious liver injury mean the drug’s benefits can no longer be shown to outweigh its risks.
